Uterine cancer in Maryland: Impact of surgeon case volume and other prognostic factors on short-term mortality Fulltext Access 5 Pages 2006
Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma Fulltext Access 5 Pages 2006
Peritoneal tuberculosis mimicking advanced ovarian cancer: A retrospective review of 22 cases Fulltext Access 5 Pages 2006
Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines Fulltext Access 5 Pages 2006
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer Fulltext Access 5 Pages 2006
Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data Fulltext Access 5 Pages 2006
Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: A Phase II Study of the Gynecologic Oncology Group Fulltext Access 5 Pages 2006
Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: A rare association of a high-risk endometrial cancer with an estrogenic ovarian tumor Fulltext Access 5 Pages 2006
Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: A case report and review of the literature Fulltext Access 5 Pages 2006
Pelvic bone complications following radiation therapy of gynecologic malignancies: Clinical evaluation of radiation-induced pelvic insufficiency fractures Fulltext Access 5 Pages 2006
The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma Fulltext Access 5 Pages 2006
Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors Fulltext Access 5 Pages 2006
Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: A phase I/II study of the Gynecologic Oncology Group Fulltext Access 5 Pages 2006
Malignancies following in situ cervical cancer in Hispanic Americans and non-Hispanic Whites Fulltext Access 5 Pages 2006
CD105 expression is an independent predictor of survival in patients with endometrial cancer Fulltext Access 5 Pages 2006
Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy Fulltext Access 5 Pages 2006
Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma Fulltext Access 5 Pages 2006
Participation of the general gynecologist in surgical staging of endometrial cancer: Analysis of cost and perioperative outcomes Fulltext Access 5 Pages 2006
KRAS and BRAF mutations in ovarian tumors: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants Fulltext Access 5 Pages 2006
Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Fulltext Access 5 Pages 2006
Development of an immunocytokine, IL-2-183B2scFv, for targeted immunotherapy of ovarian cancer Fulltext Access 5 Pages 2006
Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva Fulltext Access 5 Pages 2006
Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy Fulltext Access 5 Pages 2006
Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free β-subunit, a reliable marker of placental site trophoblastic tumors Fulltext Access 5 Pages 2006
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer Fulltext Access 5 Pages 2006
Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: Report of two cases and a possible new histological subtype Fulltext Access 5 Pages 2006
Surgical morbidity associated with radical trachelectomy and radical hysterectomy Fulltext Access 5 Pages 2006
Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence Fulltext Access 5 Pages 2006
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study Fulltext Access 5 Pages 2006
Persistent HPV infection after conization in patients with negative margins Fulltext Access 5 Pages 2006
Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer Fulltext Access 5 Pages 2006
Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer Fulltext Access 5 Pages 2006
The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma Fulltext Access 5 Pages 2006
Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix Fulltext Access 5 Pages 2006
Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes? Fulltext Access 5 Pages 2006
Role of prophylactic hysterectomy in patients at high risk for hereditary cancers Fulltext Access 5 Pages 2006
Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy Fulltext Access 5 Pages 2006
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center Fulltext Access 5 Pages 2006
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance Fulltext Access 5 Pages 2006
The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma Fulltext Access 5 Pages 2006
Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma Fulltext Access 5 Pages 2006
Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer Fulltext Access 5 Pages 2006
Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB–IIA cervical cancer Fulltext Access 5 Pages 2006
Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines Fulltext Access 5 Pages 2006
Phase II Trial of Adjuvant Gemcitabine plus Cisplatin-Based Chemotherapy in Patients with Locally Advanced Bladder Cancer Fulltext Access 5 Pages 2006
Highlights from: The 42nd Annual Meeting of the American Society of Clinical Oncology; Atlanta, GA; June 2-6, 2006 Fulltext Access 5 Pages 2006
Gene Expression Profiling in Kidney Cancer: Combining Differential Expression and Chromosomal and Pathway Analyses Fulltext Access 5 Pages 2006
A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer Fulltext Access 5 Pages 2006
The prognostic value of positron emission tomography in non-small cell lung cancer: Analysis of 266 cases Fulltext Access 5 Pages 2006
Analysis of c-kit expression in small cell lung cancer: Prevalence and prognostic implications Fulltext Access 5 Pages 2006
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age â¤65 and performance status 2 Fulltext Access 5 Pages 2006
Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer Fulltext Access 5 Pages 2006
Large cell neuroendocrine carcinoma of the lung: A retrospective analysis of 144 surgical cases Fulltext Access 5 Pages 2006
Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer Fulltext Access 5 Pages 2006
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer Fulltext Access 5 Pages 2006
Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer Fulltext Access 5 Pages 2006
Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects Fulltext Access 5 Pages 2006
Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer Fulltext Access 5 Pages 2006
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial Fulltext Access 5 Pages 2006
A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer Fulltext Access 5 Pages 2006
Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial Fulltext Access 5 Pages 2006
Role of preoperative chemotherapy for non-small-cell lung cancer: A meta-analysis Fulltext Access 5 Pages 2006
Gastro-intestinal metastasis of primary lung carcinoma: Clinical presentations and outcome Fulltext Access 5 Pages 2006
A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome Fulltext Access 5 Pages 2006
Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer Fulltext Access 5 Pages 2006
Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: A randomised trial Fulltext Access 5 Pages 2006
Patient demographics and treatment for early breast cancer: An observational study Fulltext Access 5 Pages 2006
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Fulltext Access 5 Pages 2006
Relationship between prognostic factors of breast cancer and 99mTc-sestamibi uptake in patients who underwent scintimammography: Multivariate analysis of causes of false-negative results Fulltext Access 5 Pages 2006
Secondary breast, pancreatic, and renal involvement with non-Hodgkin's lymphoma: Imaging findings Fulltext Access 5 Pages 2006
Validity of needle core biopsy in the histological characterisation of mammary lesions Fulltext Access 5 Pages 2006
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer Fulltext Access 5 Pages 2006
Cancer detection and mammogram volume of radiologists in a population-based screening programme Fulltext Access 5 Pages 2006
Two-week rule: Has prioritisation of breast referrals by general practitioners improved? Fulltext Access 5 Pages 2006
The impact of image guided needle biopsy on the outcome of mammographically detected indeterminate microcalcification Fulltext Access 5 Pages 2006
Breast conservation without mammography? Oncology practice in the real world of limited resource countries Fulltext Access 5 Pages 2006
The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: Results of an experimental study Fulltext Access 5 Pages 2006
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression Fulltext Access 5 Pages 2006
Systematic cavity shaves reduces close margins and re-excision rates in breast conserving surgery Fulltext Access 5 Pages 2006
“You've got mail!”: The role of e-mail in clinical breast surgical practice Fulltext Access 5 Pages 2006
Schwannoma of the breast showing massive exophytic growth: A case report Fulltext Access 5 Pages 2006
Computer-aided detection (CAD) of cancers detected on double reading by one reader only Fulltext Access 5 Pages 2006
Objective analyses of mastalgia in breast clinics: Is breast pain questionaire a useful tool in a busy breast clinic? Fulltext Access 5 Pages 2006
Best surgical prophylaxis - risk-reducing mastectomy for women at high personal risk of breast cancer Fulltext Access 5 Pages 2006
Therapeutic Considerations in Patients with Metastatic Renal Cell Carcinoma Previously Treated with Antiangiogenic Therapies Fulltext Access 5 Pages 2006